DRTG(SH:600329) Shang Hai Zheng Quan Bao·2025-08-13 18:47Group 1 - The company, Tianjin ZHONGXIN Pharmaceutical Group Co., Ltd., has announced the closure of certain fundraising accounts as part of its financial management strategy [1][5]. - The company raised a total of RMB 836,079,987.68 through a non-public offering of shares in June 2015, with a net amount of RMB 814,340,000.00 after deducting various fees [2]. - The company has established a fundraising management method to ensure compliance with relevant laws and regulations, enhancing the efficiency of fund usage and protecting investor rights [3]. Group 2 - As of the announcement date, the company has completed the closure of specific fundraising accounts related to projects such as the "Terminal Marketing Network and Promotion System Project" and the "Bozhou Industrial Park Construction Project" [5]. - The company has transferred surplus funds and interest generated from the fundraising to its respective accounts and has terminated the regulatory agreements associated with the closed accounts [5]. - The company’s name was officially changed to Tianjin ZHONGXIN Pharmaceutical Group Co., Ltd. on May 18, 2022 [4].